Speakers

Karen Aiach-Pignet

CEO

Genespire

Andre Albergaria

Principal

Biovance Capital

Marco Baccanti

Director

FITT Foundation

Jesus Baena

BD&L Transactions Oncology Director

Novartis

Thomas Ballotti

Scientific Officer

European Medicines Agency

Stefan Bartl

CEO & CSO

HD Immune GmbH

Tarig Bashir

CEO

FoRx Therapeutics AG

Ann Belien

Founder and CEO

Rejuvenate Biomed

Daniela Bellomo

Director of Business Development Division

Ospedale San Raffaele

Yehezkel ben-ari

CEO

Neurochlore

Steve Berman

Deputy VP, Science and Regulatory Affairs Strategy

Biotechnology Innovation Organization (BIO)

Louis-Philippe Bernier

CEO

CereCura Nanotherapeutics

Talia Biran

President

Oncolys BioPharma

Hubert Birner

Managing Partner

TVM Capital

Greg Bosch

CEO

Persevere Therapeutics

Celine Bouquet

Business Development Neuroscience, Ophthalmology and Rare Diseases

Roche

Delphine Bourdon

VP, Head of International Finance

Blueprint Medicines

Philip Brainin

Associate

Sound Bioventures

Harold Brakewood

CBO

Immuneering Corporation

Fabrizio Calisti

Medical Director

Angelini Ventures

Gabriella Camboni

Partner

Sofinnova Partners

Vanessa Carle

Senior Associate

Forbion

Massimo Carnelos

Head of Technological Innovation and Startups

Italian Ministry of Foreign Affairs and International Cooperation

Robin Carr

CEO

MyricxBio

Michelle Chen

CBO

Insilico Medicine

Jung Jong Cho

Head of Bio Business Division

Kolon Life Science

Sea Choi

Co-Founder/ Chief Global Strategist

Biorevert Inc.

Mary Clark

CEO

Optimum Strategic Communications

Niels Clausen

CEO & Co-Founder

HHC Medical

Fabrizio Conicella

VP - Center of Open Innovation & Competence

Chiesi Group

Anu Connor

VP, Head of Oncology External Innovation

IPSEN

Maria Cristina Porta

Director General

ENEA Tech and Biotech Foundation

Anne Dagallier

Business Development Director Global Lead Oncology

Servier

Riccardo Dainese

CEO

Alithea Genomics SA

Robert Darwin

Private Equity/Life Sciences & Healthcare Partner

Sidley Austin LLP

Peter de Keizer

Managing Director

Cleara Biotech

Francesco De Rubertis

Co-Founder and Partner

Medicxi

Matteo Giovanni Della Porta

Director, Leukemia Unit

Humanitas Research Hospital

Damien Dessis

CBO

Ziphius NV

Luca Durante

Manager of Technology Promotion Office

Italian Trade Agency

Hilmar Ebersbach

CSO

Immunos Therapeutics

Nizar El Murr

Associate Director Search and Evaluation, Rare and Neurological Disorders

Sanofi

Lucie Ellis-Taitt

Executive Director - In Vivo

Citeline

Andreas Emmenegger

CFO and CBO

Swiss Rockets AG

Simon Fagg

Founder

With Leadership

Laura Faravelli

VP Business Development

Newron Pharmaceuticals

Batoul Farhat

Head of Business Development

Altevax

Jonathon Fendelman

Business Development

Pharming Group N.V.

Igor Fisch

CEO

NewBiologix

Michael French

CEO and Founder

Amaro Therapeutics, Inc.

George Frodsham

Founder & CEO

MediSieve

Nick Gagnon

VP, Head of Oncology Global Partnering

IPSEN

Rakhee Ganti

Founder and CEO

Dimer Pharmaceuticals

Daniel Ghyssels

VP, Commercial Europe

Immunocore

Darren Gibson

Executive Director

Frontier Science (Scotland) Limited

Hakan Goker

Managing Director

M Ventures

Marco Gorini

Head of Digital Health and Innovation

AstraZeneca

Glen Gowers

CEO

Basecamp Research

Guido Grandi

Professor

BiOMViS Srl

Anton Gueth

Managing Director

EVOLUTION Life Science Partners

Franz-Werner Haas

CEO

LimmaTech Biologics AG

William Haskins

Co-Founder and CEO

Owl Therapeutics

Edward Hodgkin

Managing Partner

Syncona

Regina Hodits

Managing Partner

Wellington Partners

Blake Hopiavuori

Associate Director

Abbvie

Tiina Kahkonen

CSO

OncoBone Therapeutics Ltd

Konstantina Katcheves

SVP, Global Business Development and Acquisitions

Teva Pharmaceuticals

Peter Kayatz

CEO

Sola Diagnostics GmbH

Nisit Khandelwal

CEO

Cycuria Therapeutics GmbH

Shyam Khatau

VP, Life Sciences

Tempus AI

Neal Koller

CEO

Alphyn Biologics

Gergely Krajcsi

Senior Investment Officer for Life Science & Biotech Growth Finance & Venture Debt

European Investment Bank

Nikolaus Krall

Managing Director

Exscientia GmbH

Libby Kruse

Trade Manager, Health and Life Sciences

The State Government of Victoria Australia

Jenny Laird

VP Search & Evaluation

Eli Lilly and Company

Anna Lambiase

Chairwomen

CDP Venture Capital SGR SpA

Tomas Landh

Innovation Sourcing VP, Senior Principal Scientist Search and Evaluation

Novo Nordisk

Laura Lane

VP Lilly Ventures , European Head

Eli Lilly & Company

James Lapworth

CBO

NanoSyrinx Ltd

Seth Lederman

CEO

Tonix Pharmaceuticals Holding Corp.

Catherine Lee

Director

TAHO Pharmaceuticals

Juliette Lee

VP

EQT Life Sciences

Yuta Lee

CEO

Accelerated Biosciences Corp.

Marc Lerchenmüller

Managing Director and CFO

AaviGen

Chiara Liberati

Managing Director

Golgi Neurosciences SrL

Fiorenza Lipparini

Director General

Milano&Partners

Paul Little

CEO

Vesper Bio

Henrik Luessen

CBO

Eleva GmbH

Stipe Lukin

CEO

KalphaTech

Angela Luttick

EVP, Commercial

360biolabs

Claire Macht

Portfolio Director, Europe

EBD Group

Will Maier

Senior Vice President, Drug Development Solutions

ICON Biotech

Robert Z. Mamoun

CEO

Ciloa

Tilo Mandry

Lead International Liaison Manager

IGES Institut GmbH

Daniel Marshall

European Search & Evaluation, Business Development & Licensing

MSD

Tom McCorkle

CEO

IowaIBO, Inc

Fiona McLaughlin

Senior Director

Johnson & Johnson

Jason Mellad

Co-Founder

Start Codon

Hans Melo

CEO

Menten AI, Inc.

Robert Miller

CMO

Hubro BioScience

Graham Mills

Principal

Abingworth LLP

Natalia Misciattelli

CEO

AAVantgarde Bio

Faical Miyara

CBO

IO Biotech

Martina Molsbergen

CEO

C14 Consulting Group, LLC

Gabriele Morabito

Drug Delivery

Symbiotica Therapeutics

Matthias Muellenbeck

SVP, Head Global Business Development & Alliance Management

Merck Healthcare KGaA

Luigi Naldini

Director, SR-TIGET

San Raffaele Telethon Institute for Gene Therapy

Millie Nelson

Editor of BioXconomy

Informa

Gordon Ngan

VP, Business Development

KisoJi Biotechnology Inc.

Marica Nobile

Director

Federchimica Assobiotec

Peter Nolan

CEO

BlackfinBio Ltd

Christoffer Norn

Entrepreneur in Residence

BioInnovation Institute, Modulate

Natalia Novac

CEO & Chairwoman

Phialogics

Poullette Oduor

COO

Klas Therapeutics

Jorgen Olsen

CEO

EnteroTarget ApS

Kfir Oved

CEO, Founder

Canopy Immuno Therapeutics

Harald Pacl

CEO

Mitodicure GmbH

Pierluigi Paracchi

CEO of Genenta Science, Moderator of the National Working Table for the Internationalization of the Biotechnology Sector, and Member of the Executive Committee of Assobiotec

Assobiotec

Francesca Pasinelli

Managing Director

Fondazione Telethon

William Pay

Venture Partner

Pappas Capital

Matteo Picariello Signori

Head of the Global Startup Program

ICE Milano

Barnaby Pickering

Freelance Writer, Account Executive

RHA Communications

Catherine Pickering

CEO

iOnctura

Tom Plitz

CEO

Precirix

Carolina Pola

CEO

STAb Therapeutics

Paola Pozzi

Partner

Sofinnova Partners

Linda Pullan

Business Development Consultant, founder

Pullan Consulting

Pavel Reddy

Director

GLOBAL R&D

Jonathan Rees

CEO

MitoRx Therapeutics Limited

Heiko Richtzenhain

Head of Sales and Business Development

Menarini Biotech

Giovanni Rizzo

Partner Biotech Fund

Indaco Venture Partners

Megan Robertson

Director of Research

St Vincent's Hospital Melbourne

Robert Rushenberg

CEO

Verdant Scientific, Inc.

Brian S. Kim

Sol and Clara Kest Professor of Dermatology and Co-Founder

Icahn School of Medicine at Mount Sinai and Alys Pharmaceuticals

Nerida Scott

VP, Head of Innovation EMEA

Johnson & Johnson

Graziano Seghezzi

Managing Partner

Sofinnova Partners

Evonne Sepsis

Founder and Managing Director

ESC Advisors

Charles Sermon

General Counsel and Business Development

Mereo BioPharma

Tom Shepherd

CEO

Captor Therapeutics

Jo Shorthouse

Executive Editor

In Vivo

Catello Somma

Partner

Seroba

Poul Sorensen

CEO

Inverna therapeutics

Ofer Springer

CTO and President

ProtOS

Miha Stajdohar

CTO and Co-founder

Genialis

Henning Steinhagen

CEO

Lario Therapeutics Ltd.

Jordan Stillman

Project Manager

partneringOne

Nikola Strumberger

SVP Commercial Operations Ergomed Clinical Research

Ergomed

Lovisa Sunesson

Director of Business Development

Vesper Bio

Mario Torchia

COO

InSilicoTrials

Dmitry Tsay

Licensing Transactions Director

Almirall

Sree Vadlamudi

EVP Business Development

VariationalAI

Prabhu Velusami

Senior Director, Early Innovation Partnering

Johnson & Johnson

Kristof Vercruysse

CEO

TargED Biopharmaceuticals B.V.

Gregory Vladimer

Co-Founder and CEO

Graph Therapeutics

Monika Vnuk

SVP, Global Partnering & Business Development

Sanofi

Sam Vohra

Founder & CEO

AVION Full Service CRO & Imaging Specialists

Friedrich von Bohlen

CEO

Molecular Health

Mike Ward

Global Head of Thought Leadership

Decision Resources Group, part of Clarivate

Chad Wessel

Director, Industry Analysis

Biotechnology Innovation Organization (BIO)

Craig Woods

CEO

Forge Genetics

Daozhan Yu

CEO

AAVnerGene Inc.

Sohail Zaidi

CEO

Ananda Scientific Inc

Jonas Zeller

CFO

InnoMedica Holding AG

Wei Zeng

VP

Beijing Sungen Biomedical Technology Co., Ltd

Fang Zhang

VP, Business Development

Pioneering Medicines

Laura Zhu

CBO

AmMax Bio, Inc.

Matteo Zoppas

President of ITA

Italian Trade Agency